21,99 €
inkl. MwSt.
Versandfertig in 1-2 Wochen
11 °P sammeln
Andere Kunden interessierten sich auch für
![Clinical Use of Extended-Release Injectable Naltrexone in the Treatment of Opioid Use Disorder]( "Clinical Use of Extended-Release Injectable Naltrexone in the Treatment of Opioid Use Disorder")
Clinical Use of Extended-Release Injectable Naltrexone in the Treatment of Opioid Use Disorder18,99 €![A Collaborative Approach to the Treatment of Pregnant Women With Opioid Use Disorders]( "A Collaborative Approach to the Treatment of Pregnant Women With Opioid Use Disorders")
A Collaborative Approach to the Treatment of Pregnant Women With Opioid Use Disorders23,99 €![Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings ((Evidence-based Resource Guide Series)]( "Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings ((Evidence-based Resource Guide Series)")
Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings ((Evidence-based Resource Guide Series)20,99 €![Disaster Planning Handbook for Behavioral Health Treatment Programs (TAP 34)]( "Disaster Planning Handbook for Behavioral Health Treatment Programs (TAP 34)")
Disaster Planning Handbook for Behavioral Health Treatment Programs (TAP 34)25,99 €![Medications for Opioid Use Disorder - Treatment Improvement Protocol (Tip 63)]( "Medications for Opioid Use Disorder - Treatment Improvement Protocol (Tip 63)")
Medications for Opioid Use Disorder - Treatment Improvement Protocol (Tip 63)33,99 €![Federal Plain Language Guidelines]( "Federal Plain Language Guidelines")
Federal Plain Language Guidelines23,99 €![Focus on Prevention - Strategies and Programs to Prevent Substance Use]( "Focus on Prevention - Strategies and Programs to Prevent Substance Use")
Focus on Prevention - Strategies and Programs to Prevent Substance Use38,99 €
The Federal Guidelines for Opioid Treatment Programs (Guidelines) describe the Substance Abuse and Mental Health Services Administration's (SAMHSA) expectation of how the federal opioid treatment standards found in Title 42 of the Code of Federal Regulations Part 8 (42 CFR § 8) are to be satisfied by opioid treatment programs (OTPs). Under these federal regulations, OTPs are required to have current valid accreditation status, SAMHSA certification, and Drug Enforcement Administration (DEA) registration before they are able to administer or dispense opioid drugs for the treatment of opioid addiction.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.